The role of monoclonal antibodies and the recombinant DNA technology in studying autoantibody production

Matthew D. Scharff, Ronald A. DePinho, Samuel Behar, Cori Beychok, Seung Uon Shin, Deborah French

Research output: Contribution to journalArticle

1 Scopus citations


The hybridoma technology has made it possible to sample the B-cell repertoire and to generate monoclonal antibodies which can be analyzed for their specificity and idiotypy. Using the recombinant DNA technology, the structure of the genes which encode those antibodies can be analyzed. The knowledge gained from the application of these techniques has made it possible to pose specific questions about the origins of autoantibodies.

Original languageEnglish (US)
Pages (from-to)29-37
Number of pages9
JournalCellular Immunology
Issue number1
Publication statusPublished - Apr 15 1986


ASJC Scopus subject areas

  • Immunology

Cite this